Cite
MLA Citation
Loris R. Lopetuso et al.. “The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn's disease.” Expert opinion on investigational drugs, vol. 27, 2018, pp. 543–551. http://access.bl.uk/ark:/81055/vdc_100066219948.0x00002a